Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Stuart

Showing results (401-410 of 451) with videos related to

Pageof 46
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2024
Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibitionRoi Asor, Anna Olerinyova, Sean A Burnap, et al.
Nature Communications|June 24, 2024
Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratificationKoen B Pouwels, David W Eyre, Thomas House, et al.
Nature Communications|January 18, 2025
Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccinesLee Sherry, Mohammad W Bahar, Claudine Porta, et al.
Acta Crystallographica. Section D, Structural Biology|August 5, 2016
Fixed target combined with spectral mapping: approaching 100% hit rates for serial crystallographySaeed Oghbaey, Antoine Sarracini, Helen M Ginn, et al.
Nature Communications|June 7, 2023
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapyManon Ragonnet-Cronin, Rungtiwa Nutalai, Jiandong Huo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 10, 2021
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection statusDavid W Eyre, Sheila F Lumley, Jia Wei, et al.
Proteins|November 25, 2004
Design of a data model for developing laboratory information management and analysis systems for protein productionAnne Pajon, John Ionides, Jon Diprose, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1J H Chan, J S Hong, R N Hunter, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Site-specific steric control of SARS-CoV-2 spike glycosylationJoel D Allen, Himanshi Chawla, Firdaus Samsudin, et al.
Pageof 46

Showing results (401-410 of 451) with videos related to

Sort By:
Pageof 46
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2024
Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibitionRoi Asor, Anna Olerinyova, Sean A Burnap, et al.
Nature Communications|June 24, 2024
Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratificationKoen B Pouwels, David W Eyre, Thomas House, et al.
Nature Communications|January 18, 2025
Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccinesLee Sherry, Mohammad W Bahar, Claudine Porta, et al.
Acta Crystallographica. Section D, Structural Biology|August 5, 2016
Fixed target combined with spectral mapping: approaching 100% hit rates for serial crystallographySaeed Oghbaey, Antoine Sarracini, Helen M Ginn, et al.
Nature Communications|June 7, 2023
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapyManon Ragonnet-Cronin, Rungtiwa Nutalai, Jiandong Huo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 10, 2021
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection statusDavid W Eyre, Sheila F Lumley, Jia Wei, et al.
Proteins|November 25, 2004
Design of a data model for developing laboratory information management and analysis systems for protein productionAnne Pajon, John Ionides, Jon Diprose, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1J H Chan, J S Hong, R N Hunter, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Site-specific steric control of SARS-CoV-2 spike glycosylationJoel D Allen, Himanshi Chawla, Firdaus Samsudin, et al.
Pageof 46